UK 02:59 Friday, 30 October 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
In part one of this two part look at Utilitywise plc (UTW), I highlighted areas of particular interest in the accounts. The following reviews post announcements from the company this week, including of a “Change to payment terms with existing supplier”…
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Comments
Mammy Yoko
The so-called experts have all performed abysmally in this share recently (or have completely different time horizons). By my calculations Jeremy Middleton bought 2,9m at an average price of £2.50 earlier in the year, Mr Patient is long 19.8m at an average price of £2.30 from 2014 and BlackRock shorted them at £1.50. All massively out of the money at this point.
On balance, unless aggressive accounting turns out to be false accounting (which I doubt), my money is on Mr Patient and BlackRock will take a caning.
winsome147
You wouldn’t bet against Neil Woodford though, would you? He did a site visit recently and thoroughly analysed the books and topped up his clients’ portfolio afterwards to 20% of the company.
The accrued revenue is against the big energy companies mainly who are guaranteed to pay unless they go bust.